Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06886737 · ClinicalTrials.gov registry record · Phase 1
Home-based Vision Therapy
A Phase 1 study of Convergence Insufficiency, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 45
- Enrollment target
- 1
- Study location
NCT06886737: Recruiting Phase 1 study of Convergence Insufficiency, sponsored by VA Office of Research and Development.
NCT06886737 is a Phase 1 study of Convergence Insufficiency that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 45 participants, below the 118-participant average among 6 other Convergence Insufficiency trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06886737, a Phase 1 study of Convergence Insufficiency, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
Post-concussive vision symptoms affect many Veterans who have experienced traumatic brain injury (TBI). One common issue is trouble with near vision, a problem that may persist long after the acute injury. Double vision or difficulty focusing on close objects can affect reading and depth perception. Poor reading can interfere with academic or work performance, and loss of near focusing can affect jobs that require fine motor tasks like machining and electrical work. Even having trouble using a smartphone can have a substantial impact on both work and social function. Near vision impairment after TBI is not well understood, and treatments are limited. The goal of this project is to investigate novel virtual-reality assessments and training games to improve the near vision diagnosis and home-based rehabilitation. Restoring normal near vision function could have a large impact on the fulfillment of Veterans' educational, career, and overall life goals.
Primary Outcome
The near point of convergence (angle of maximum ocular convergence) will be measured using a custom virtual-reality application.
Conditions Studied
Interventions
- OTHER Virtual-reality convergence training game
Study Locations (1)
Ohio
- Louis Stokes VA Medical Center, Cleveland, OH - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2026-01-14 |
| Est. Completion | 2028-09-30 |
| Phase | Phase 1 |
What NCT06886737 shows while recruiting
NCT06886737 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 118-participant average among 6 other Convergence Insufficiency trials with a reported enrollment target (62% lower).
The record links to 1 condition, with Convergence Insufficiency appearing as the primary indexed condition, and to 1 intervention - of which Virtual-reality convergence training game is the first listed.
NCT06886737 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT06886737 about?
NCT06886737 is a clinical study titled "Home-based Vision Therapy". Post-concussive vision symptoms affect many Veterans who have experienced traumatic brain injury (TBI). One common issue is trouble with near vision, a problem that may persist long after the acute injury. Double vision or difficulty focusing on close objects can affect reading and depth perception....
What is the current status of trial NCT06886737?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 45 participants. The study started on 2026-01-14. Estimated completion is 2028-09-30.
What conditions does trial NCT06886737 study?
This clinical trial studies the following conditions: Convergence Insufficiency.
What interventions are being tested in trial NCT06886737?
The interventions under investigation include: Virtual-reality convergence training game (OTHER).
Who is sponsoring clinical trial NCT06886737?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06886737 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Convergence Insufficiency
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Effectiveness of Virtual Reality Vision Therapy - VERVE
RECRUITING · Early Phase 1
-
Eye Recovery Automation for Post Injury Dysfunction (iRAPID)
RECRUITING · NA
-
Non-invasive Brain Stimulation for Treating Symptomatic Convergence Insufficiency
RECRUITING · NA
-
Neural Mechanism of Vision Therapy for Patients With Convergence Insufficiency
COMPLETED · NA
-
A Prospective Observational Study of Adult Strabismus
COMPLETED
-
Eyetracking and Neurovision Rehabilitation of Oculomotor Dysfunction in Mild Traumatic Brain Injury
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI